• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非侵入式血红蛋白筛查设备:一种通过常规筛查和及时干预来降低贫血患病率的有前途的数字化方法。

Non-invasive hemoglobin screening device: a promising digital method for reducing anemia prevalence through routine screening and timely intervention.

机构信息

EzeRx Health Tech Private Limited, Bhubaneswar, India.

SARU Foundation, Noida, India.

出版信息

Hematology. 2024 Dec;29(1):2365078. doi: 10.1080/16078454.2024.2365078. Epub 2024 Jun 12.

DOI:10.1080/16078454.2024.2365078
PMID:38864489
Abstract

BACKGROUND

Several non-invasive technologies are nowadays available in the market which claim to determine the hemoglobin levels instantly without the requirement of the blood sample. But no study has shown the significance of such non-invasive devices on a routine basis for determining their impact on anemia reduction programs. This study is conducted to determine the impact of regular hemoglobin screening on the women population to determine its potential in reducing anemia, using a digitalized non-invasive device.

METHOD

A cross-sectional study was conducted on 203 women of reproductive age group, residing in the Moradabad district. Repetitive readings were taken after a time interval of a minimum of 1 month for determining the impact of regular screening. The entire data collection process was carried out using the EzeCheck mobile app.

RESULTS

It was observed that the prevalence of anemia was reduced upon the second time screening and was accepted by the women population. Repetitive testing has a significant impact on reducing anemia prevalence. Also, the simplified non-invasive technology for estimating the hemoglobin values, makes the user more comfortable to take the test.

CONCLUSION

Non-invasive devices should be used regularly to keep track of hemoglobin levels which will help in the effective treatment of anemia. The mobile app-based testing could help to easily evaluate the reports of the patients from any remote location with instant result interpretation and health assistance.

摘要

背景

目前市场上有几种非侵入性技术声称可以即时确定血红蛋白水平,而无需采集血样。但尚无研究表明此类非侵入性设备在常规基础上的重要性,以确定它们对贫血减少计划的影响。本研究旨在使用数字化非侵入性设备确定定期血红蛋白筛查对女性人群的影响,以确定其在减少贫血方面的潜力。

方法

对居住在莫拉达巴德地区的 203 名育龄妇女进行了横断面研究。在至少 1 个月的时间间隔后进行重复读数,以确定定期筛查的影响。整个数据收集过程都是使用 EzeCheck 移动应用程序进行的。

结果

第二次筛查时贫血的患病率有所下降,并被妇女群体所接受。重复检测对降低贫血患病率有显著影响。此外,用于估计血红蛋白值的简化非侵入性技术,使用户更愿意进行测试。

结论

应定期使用非侵入性设备来跟踪血红蛋白水平,这将有助于贫血的有效治疗。基于移动应用程序的测试可以帮助从任何远程位置轻松评估患者的报告,并进行即时结果解释和健康援助。

相似文献

1
Non-invasive hemoglobin screening device: a promising digital method for reducing anemia prevalence through routine screening and timely intervention.非侵入式血红蛋白筛查设备:一种通过常规筛查和及时干预来降低贫血患病率的有前途的数字化方法。
Hematology. 2024 Dec;29(1):2365078. doi: 10.1080/16078454.2024.2365078. Epub 2024 Jun 12.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.使用移动应用程序与其他方法收集的自我管理调查问卷回复的比较。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):MR000042. doi: 10.1002/14651858.MR000042.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.
7
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study.数字病理学与光学显微镜检查在组织病理学切片诊断中的内部及相互间差异:双盲交叉对比研究
Health Technol Assess. 2025 Jul;29(30):1-75. doi: 10.3310/SPLK4325.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

引用本文的文献

1
Evaluating the Feasibility and Cost-Effectiveness of EzeCheck for Hemoglobin Screening Across India.评估EzeCheck在印度进行血红蛋白筛查的可行性和成本效益。
Cureus. 2024 Nov 3;16(11):e72945. doi: 10.7759/cureus.72945. eCollection 2024 Nov.